Randomized, Double-blind Phase 2 Study Of Axitinib (Ag-013736) With Or Without Dose Titration In Patients With Metastatic Renal Cell Carcinoma
Randomized, Double-blind Phase 2 Study Of Axitinib (Ag-013736) With Or Without Dose Titration In Patients With Metastatic Renal Cell Carcinoma
Axitinib dose titration (giving a higher dose of the drug above its standard starting dose) among certain patients may improve the response to treatment.
Inclusion Criteria:
Exclusion Criteria:
Antioch, California 94531, United States
Pleasant Hill, California 94523, United States
Pleasant Hill, California 94523, United States
San Leandro, California 94578, United States
ĆstĆ nad Labem, 401 13, Czechia
Hanover, 30625, Germany
Chuo-ku, Tokyo 104-0045, Japan
Koto-ku, Tokyo 135-8550, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Obninsk, Kaluga Oblast 249036, Russia
Poselok Kuzmolovskiy, Vsevolozhskiy Region, Leningradskaya Oblast 188663, Russia
Saint Petersburg, 197022, Russia
Saint Petersburg, 198255, Russia